Biomedicines
Rationally Designed Dual Kinase Inhibitors for Management of Obstructive Sleep Apnea-A Computational Study.
Kosi Gramatikoff, Miroslav Stoykov, Mario Milkov
Published: 202610.3390/biomedicines14010181
Abstract
Background/Objectives: Obstructive sleep apnea (OSA) affects approximately 1 billion adults worldwide with extensive comorbidities, including cardiovascular disease, metabolic disorders, and cognitive decline, yet pharmacological therapies remain lim…
Preview only. Read the full abstract at the source